All the Tested Human Somatic Cells Express Both Oct4A and Its Pseudogenes but Express Oct4A at Much Lower Levels Compared with Its Pseudogenes and Human Embryonic Stem Cells

Stem Cells and Development

Volumn 24, Issue 13, 2015, Pages 1546-1557

  Xu, Guangzu ^a   Yang, Ling ^a   Zhang, Weixiong ^a   Wei, Xing ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4 PG1; OCTAMER TRANSCRIPTION FACTOR 4 PG3; OCTAMER TRANSCRIPTION FACTOR 4 PG4; OCTAMER TRANSCRIPTION FACTOR 4A; UNCLASSIFIED DRUG; POU5F1 PROTEIN, HUMAN;

ARTICLE; CELL CLONE; CLONE; CONTROLLED STUDY; EMBRYONIC STEM CELL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PSEUDOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL DETECTION; SOMATIC CELL; ADOLESCENT; ADULT; CELL CULTURE; CHILD; FEMALE; GENETICS; MALE; MESENCHYMAL STROMA CELL; METABOLISM;

ADOLESCENT; ADULT; CELLS, CULTURED; CHILD; EMBRYONIC STEM CELLS; FEMALE; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PSEUDOGENES; RNA, MESSENGER;

EID: 84931292389     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0552     Document Type: Article

References (75)

1. Wang X and J Dai. (2010). Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology. Stem Cells 28:885-893.
2. Cauffman G, I Liebaers, A Van Steirteghem and H Van De Velde. (2006). POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells 24:2685-2691.
3. Seo KW, SR Lee, DR Bhandari, KH Roh, SB Park, AY So, JW Jung, MS Seo, SK Kang, et al. (2009). OCT4A contributes to the stemness and multipotency of human umbilical cord blood-derived multipotent stem cells (hUCB-MSCs). Biochem Biophys Res Commun 384:120-125.
4. Lee J, HK Kim, JY Rho, YM Han and J Kim. (2006). The human OCT-4 isoforms differ in their ability to confer self-renewal. J Biol Chem 281:33554-33565.
5. Gao Y, J Wei, J Han, X Wang, G Su, Y Zhao, B Chen, Z Xiao, J Cao, et al. (2012). The novel function of OCT4B isoform-265 in genotoxic stress. Stem Cells 30:665-672.
6. Wang X, Y Zhao, Z Xiao, B Chen, Z Wei, B Wang, J Zhang, J Han, Y Gao, et al. (2009). Alternative translation of OCT4 by an internal ribosome entry site and its novel function in stress response. Stem Cells 27:1265-1275.
7. Farashahi Yazd E, MR Rafiee, M Soleimani, M Tavallaei, MK Salmani and SJ Mowla. (2011). OCT4B1, a novel spliced variant of OCT4, generates a stable truncated protein with a potential role in stress response. Cancer Lett 309:170-175.
8. Gao Y, X Wang, J Han, Z Xiao, B Chen, G Su and J Dai. (2010). The novel OCT4 spliced variant OCT4B1 can generate three protein isoforms by alternative splicing into OCT4B. J Genet Genomics 37:461-465.
9. Panagopoulos I, E Möller, A Collin and F Mertens. (2008). The POU5F1P1 pseudogene encodes a putative protein similar to POU5F1 isoform 1. Oncol Rep 20:1029-1033.
10. Suo G, J Han, X Wang, J Zhang, YN Zhao, YH Zhao and J Dai. (2005). Oct4 pseudogenes are transcribed in cancers. Biochem Biophys Res Commun 337:1047-1051.
11. Zhao S, Q Yuan, H Hao, Y Guo, S Liu, Y Zhang, J Wang, H Liu, F Wang, et al. (2011). Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma. J Pathol 223:672-682.
12. Cheng L, MT Sung, P Cossu-Rocca, TD Jones, GT Maclennan, JD Jong, A Lopez-Beltran, R Montironi and LH Looijenga. (2007). OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol 211:1-9.
13. de Jong J and LH Looijenga. (2006). Stem cell marker OCT3/4 in tumor biology and germ cell tumor diagnostics: history and future. Crit Rev Oncog 12:171-203.
14. Ding DC, WC Shyu and SZ Lin. (2010). Mesenchymal stem cells. Cell Transplant 20:5-14.
15. Rankin S. (2012). Mesenchymal stem cells. Thorax 67: 565-566.
16. Hu W, FX Guan, Y Li, YJ Tang, F Yang and B Yang. (2013). New methods for inducing the differentiation of amniotic-derived mesenchymal stem cells into motor neuron precursor cells. Tissue Cell 45:295-305.
17. Singh SP, NK Tripathy and S Nityanand. (2013). Comparison of phenotypic markers and neural differentiation potential of multipotent adult progenitor cells and mesenchymal stem cells. World J Stem Cells 5:53-60.
18. Darzi S, AH Zarnani, M Jeddi-Tehrani, K Entezami, E Mirzadegan, MM Akhondi, S Talebi, M Khanmohammadi and S Kazemnejad. (2012). Osteogenic differentiation of stem cells derived from menstrual blood versus bone marrow in the presence of human platelet releasate. Tissue Eng Part A 18:1720-1728.
19. Leyva-Leyva M, L Barrera, C Lopez-Camarillo, L Arriaga- Pizano, G Orozco-Hoyuela, EM Carrillo-Casas, J Calderón- Pérez, A López-Díaz, F Hernandez-Aguilar, et al. (2013). Characterization of mesenchymal stem cell subpopulations from human amniotic membrane with dissimilar osteoblastic potential. Stem Cells Dev 22:1275-1287.
20. Lee Y, J Jung, KJ Cho, SK Lee, KW Park, IH Oh and GJ Kim. (2013). Increased SCF/c-kit by hypoxia promotes autophagy of human placental chorionic plate-derived mesenchymal stem cells via regulating the phosphorylation of mTOR. J Cell Biochem 114:79-88.
21. Fatimah SS, GC Tan, K Chua, MM Nur Fariha, AE Tan and AR Hayati. (2013). Stemness and angiogenic gene expression changes of serial-passage human amnion mesenchymal cells. Microvasc Res 86:21-29.
22. Allegra A, R Altomare, P Curcio, A Santoro, AI Lo Monte, S Mazzola and A Marino. (2013). Gene expression of stem cells at different stages of ontological human development. Eur J Obstet Gynecol Reprod Biol 170:381-386.
23. Lee MW, DS Kim, KH Yoo, HR Kim, IK Jang, IH Lee, SY Kim, MH Son, SH Lee, et al. (2013). Human bone marrow-derived mesenchymal stem cell gene expression patterns vary with culture conditions. Blood Res 48:107-114.
24. Tsai CC, PF Su, YF Huang, TL Yew and SC Hung. (2012). Oct4 and Nanog directly regulate Dnmt1 to maintain self-renewal and undifferentiated state in mesenchymal stem cells. Mol Cell 47:169-182.
25. Wu J, GT Huang, WX He, P Wang, ZC Tong, Q Jia, LP Dong, ZY Niu and LX Ni. (2012). Basic fibroblast growth factor enhances stemness of human stem cells from the apical papilla. J Endod 38:614-622.
26. Yu KR, SR Yang, JW Jung, H Kim, K Ko, DW Han, SB Park, SW Choi, SK Kang. (2012). CD49f enhances multipotency and maintains stemness through the direct regulation of OCT4 and SOX2. Stem Cells 30:876-887.
27. Nazarov I, JW Lee, E Soupene, S Etemad, D Knapik, W Green, E Bashkirova, XH Fang, MA Matthay, et al. (2012). Multipotent stromal stem cells from human placenta demonstrate high therapeutic potential. Stem Cells Transl Med 1:359-372.
28. Ball SG, A Shuttleworth and CM Kielty. (2012). Inhibition of platelet-derived growth factor receptor signaling regulates Oct4 and Nanog expression, cell shape, and mesenchymal stem cell potency. Stem Cells 30:548-560.
29. Jeon BG, BM Kumar, EJ Kang, SA Ock, SL Lee, DO Kwack, JH Byun, BW Park and GJ Rho. (2011). Characterization and comparison of telomere length, telomerase and reverse transcriptase activity and gene expression in human mesenchymal stem cells and cancer cells of various origins. Cell Tissue Res 345:149-161.
30. Arufe MC, A De la Fuente, J Mateos, I Fuentes, FJ De Toro and FJ Blanco. (2010). Analysis of the chondrogenic potential and secretome of mesenchymal stem cells derived from human umbilical cord stroma. Stem Cells Dev 20: 1199-1212.
31. Li ZL, CX Liu, ZH Xie, PY Song, RC Zhao, L Guo, ZG Liu and YJ Wu. (2011). Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation. PLoS One 6:e20526.
32. Karaöz E, A Okçu, G Gacar, S Yürüker, Ö Saʇlam and H Kenar. (2011). A comprehensive characterization study of human bone marrow mscs with an emphasis on molecular and ultrastructural properties. J Cell Physiol 226:1367-1382.
33. Trubiani O, SF Zalzal, R Paganelli, M Marchisio, R Giancola, J Pizzicannella, HJ BüHring, M Piattelli, S Caputi, et al. (2010). Expression profile of the embryonic markers nanog, OCT-4, SSEA-1, SSEA-4, and frizzled-9 receptor in human periodontal ligament mesenchymal stem cells. J Cell Physiol 225:123-131.
34. Riekstina U, I Cakstina, V Parfejevs, M Hoogduijn, G Jankovskis, I Muiznieks, R Muceniece and J Ancans. (2009). Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis. Stem Cell Rev 5:378-386.
35. Reed SA and SE Johnson. (2008). Equine umbilical cord blood contains a population of stem cells that express Oct4 and differentiate into mesodermal and endodermal cell types. J Cell Physiol 215:329-336.
36. Kaltz N, A Funari, S Hippauf, B Delorme, D Noël, M Riminucci, VR Jacobs, T Häupl, C Jorgensen, et al. (2008). In vivo osteoprogenitor potency of human stromal cells from different tissues does not correlate with expression of POU5F1 or its pseudogenes. Stem Cells 26: 2419-2424.
37. Roubelakis MG, KI Pappa, V Bitsika, D Zagoura, A Vlahou, HA Papadaki, A Antsaklis and NP Anagnou. (2007). Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev 16:931-952.
38. Tondreau T, N Meuleman, A Delforge, M Dejeneffe, R Leroy, M Massy, C Mortier, D Bron and L Lagneaux. (2005). Mesenchymal stem cells derived from CD133- positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 23:1105-1112.
39. Tsai MS, Lee JL, Chang YJ and SM Hwang. (2004). Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 19:1450-1456.
40. Jez M, S Ambady, O Kashpur, A Grella, C Malcuit, L Vilner, P Rozman and T Dominko. (2014). Expression and differentiation between OCT4A and its pseudogenes in human ESCs and differentiated adult somatic cells. PLoS One 9:e89546.
41. Wezel F, J Pearson, LA Kirkwood and J Southgate. (2013). Differential expression of Oct4 variants and pseudogenes in normal urothelium and urothelial cancer. Am J Pathol 183:1128-1136.
42. Guo X and Y Tang. (2012). OCT4 pseudogenes present in human leukemia cells. Clin Exp Med 12:207-216.
43. Redshaw Z and AJ Strain. (2010). Human haematopoietic stem cells express Oct4 pseudogenes and lack the ability to initiate Oct4 promoter-driven gene expression. J Negat Results Biomed 9:2-9.
44. Ryan JM, AR Pettit, PV Guillot, JK Chan and NM Fisk. (2013). Unravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of The Emperor's New Clothes. Stem Cell Rev 9:408-421.
45. Pierantozzi E, B Gava, I Manini, F Roviello, G Marotta, M Chiavarelli and V Sorrentino1. (2010). Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2. Stem Cells Dev 20:915-923.
46. Potdar PD and SB D'Souza. (2010). Ascorbic acid induces in vitro proliferation of human subcutaneous adipose tissue derived mesenchymal stem cells with upregulation of embryonic stem cell pluripotency markers Oct4 and SOX 2. Hum Cell 23:152-155.
47. Barrand S and P Collas. (2010). Chromatin states of core pluripotency-associated genes in pluripotent, multipotent and differentiated cells. Biochem Biophys Res Commun 391:762-767.
48. Liu TM, YN Wu, XM Guo, JH Hui, EH Lee and B Lim. (2009). Effects of ectopic Nanog and Oct4 overexpression on mesenchymal stem cells. Stem Cells Dev 18:1013-1022.
49. Mueller T, J Luetzkendorf, K Nerger, HJ Schmoll and LP Mueller. (2009). Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells. Cell Mol Life Sci 66:495-503.
50. Liedtke S, J Enczmann, S Waclawczyk, P Wernet and G Kögler. (2007). Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell 1:364-366.
51. Wei X, GF Peng, SB Zheng and XJ Wu. (2012). Differentiation of umbilical cord mesenchymal stem cells into steroidogenic cells in comparison with bone marrow mesenchymal stem cells. Cell Prolif 45:101-110.
52. Palma CS, MA Tannous, TM Malta, EM Russo, DT Covas and V Picanco-Castro. (2013). Forced expression of OCT4 influences the expression of pluripotent genes in human mesenchymal stem cells and fibroblasts. Genet Mol Res 12:1054-1060.
53. Greco SJ, K Liu and P Rameshwar. (2007). Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem Cells 25: 3143-3154.
54. Han SH, G Jang, BK Bae, SM Han, YR Koh, JO Ahn, WS Jung, SK Kang, JC Ra, et al. (2014). Effect of ectopic OCT4 expression on canine adipose tissue-derived mesenchymal stem cell proliferation. Cell Biol Int 38:1163-1173.
55. Kim JH, MK Jee, SY Lee, TH Han, BS Kim, KS Kang and SK Kang. (2009). Regulation of adipose tissue stromal cells behaviors by endogenic Oct4 expression control. PLoS One 4:e7166.
56. Huang CE, FW Hu, CH Yu, LL Tsai, TH Lee, MY Chou and CC Yu. (2014). Concurrent expression of Oct4 and Nanog maintains mesenchymal stem-like property of human dental pulp cells. Int J Mol Sci 15:18623-18639.
57. Duan P, Y Zhang, X Han, J Liu, W Yan and Y Xing. (2012). Effect of neuronal induction on NSE, Tau, and Oct4 promoter methylation in bone marrow mesenchymal stem cells. In Vitro Cell Dev Biol Anim 48:251-258.
58. Chiou SH, ML Wang, YT Chou, CJ Chen, CF Hong, WJ Hsieh, HT Chang, YS Chen, TW Lin, et al. (2010). Co-expression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res 70:10433-10444.
59. Wang YD, N Cai, XL Wu, HZ Cao, LL Xie and PS Zheng. (2013). OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathway. Cell Death Dis 4:e760.
60. Cao L, C Li, S Shen, Y Yan, W Ji, J Wang, H Qian, X Jiang, Z Li, et al. (2013). OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma. BMC Cancer 13:82.
61. Chang CJ, Y Chien, KH Lu, SC Chang, YC Chou, CS Huang, CH Chang, KH Chen, YL Chang, et al. (2011). Oct4-related cytokine effects regulate tumorigenic properties of colorectal cancer cells. Biochem Biophys Res Commun 415:245-251.
62. Hu T, S Liu, DR Breiter, F Wang, Y Tang and S Sun. (2008). Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res 68:6533-6540.
63. Kim RJ and JS Nam. (2011). Oct4 expression enhances features of cancer stem cells in a mouse model of breast cancer. Lab Anim Res 27:147-152.
64. Kumar SM, S Liu, H Lu, H Zhang, PJ Zhang, PA Gimotty, M Guerra, W Guo and X Xu. (2012). Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene 31:4898-4911.
65. Du Z, D Jia, S Liu, F Wang, G Li, Y Zhang, X Cao, EA Ling and A Hao. (2009). Oct4 is expressed in human gliomas and promotes colony formation in glioma cells. Glia 57:724-733.
66. Li C, Y Yan, W Ji, L Bao, H Qian, L Chen, M Wu, H Chen, Z Li, et al. (2012). OCT4 positively regulates Survivin expression to promote cancer cell proliferation and leads to poor prognosis in esophageal squamous cell carcinoma. PLoS One 7:e49693.
67. Chang CC, GS Shieh, P Wu, CC Lin, AL Shiau and CL Wu. (2008). Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells. Cancer Res 68:6281-6291.
68. Dai X, J Ge, X Wang, X Qian, C Zhang and X Li. (2013). OCT4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion. Oncol Rep 29:155-160.
69. Gidekel S, G Pizov, Y Bergman and E Pikarsky. (2003). Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 4:361-370.
70. Ng WL, G Chen, M Wang, H Wang, M Story, JW Shay, X Zhang, J Wang, AR Amin, et al. (2014). OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation. Cell Death Dis 5:e1024.
71. Hochedlinger K, Y Yamada, C Beard and R Jaenisch. (2005). Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121:465-477.
72. Chang JH, HK Au, WC Lee, CC Chi, TY Ling, LM Wang, SH Kao, YH Huang, CR Tzeng. (2013). Expression of the pluripotent transcription factor OCT4 promotes cell migration in endometriosis. Fertil Steril 99:1332-1339.
73. Racila D, M Winter, M Said, A Tomanek-Chalkley, S Wiechert, RL Eckert and JR Bickenbach. (2011). Transient expression of OCT4 is sufficient to allow human keratinocytes to change their differentiation pathway. Gene Ther 18:294-303.
74. Okuda T, K Tagawa, ML Qi, M Hoshio, H Ueda, H Kawano, I Kanazawa, M Muramatsu and H Okazawa. (2004). Oct-3/4 repression accelerates differentiation of neural progenitor cells in vitro and in vivo. Brain Res Mol Brain Res 132:18-30.
75. Lang KC, IH Lin, HF Teng, YC Huang, CL Li, KT Tang and SL Chen. (2009). Simultaneous overexpression of Oct4 and Nanog abrogates terminal myogenesis. Am J Physiol Cell Physiol 297:C43-C54.